These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21576642)

  • 1. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
    Elkin EB; Klem ML; Gonzales AM; Ishill NM; Hodgson D; Ng AK; Marks LB; Weidhaas J; Freedman GM; Miller RC; Constine LS; Myrehaug S; Yahalom J
    J Clin Oncol; 2011 Jun; 29(18):2466-73. PubMed ID: 21576642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
    Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
    Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
    Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
    Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
    Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer after treatment of Hodgkin's disease.
    Hancock SL; Tucker MA; Hoppe RT
    J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast carcinoma in women previously treated for Hodgkin disease: mammographic evaluation.
    Dershaw DD; Yahalom J; Petrek JA
    Radiology; 1992 Aug; 184(2):421-3. PubMed ID: 1320281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy.
    Dores GM; Anderson WF; Beane Freeman LE; Fraumeni JF; Curtis RE
    Br J Cancer; 2010 Sep; 103(7):1081-4. PubMed ID: 20842115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of breast cancer after Hodgkin's disease.
    Wolden SL; Hancock SL; Carlson RW; Goffinet DR; Jeffrey SS; Hoppe RT
    J Clin Oncol; 2000 Feb; 18(4):765-72. PubMed ID: 10673517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
    Kuo WH; Yen AM; Lee PH; Hou MF; Chen SC; Chen KM; Chen TH; Chang KJ
    Breast Cancer Res Treat; 2006 Sep; 99(2):221-8. PubMed ID: 16544057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.
    Basu SK; Schwartz C; Fisher SG; Hudson MM; Tarbell N; Muhs A; Marcus KJ; Mendenhall N; Mauch P; Kun LE; Constine LS
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):34-40. PubMed ID: 18722264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
    Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study evaluating chemotherapy tolerability for breast cancer patients who have received prior treatment and chest radiation for Hodgkin Lymphoma.
    Watson AP; Peterson B; Lee C; Baxstrom K; Turcotte L; Vogel R; Blaes A
    Cancer Treat Res Commun; 2018; 15():1-6. PubMed ID: 30207281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous and metachronous bilateral breast cancer: A long-term experience.
    Ozturk A; Alco G; Sarsenov D; Ilgun S; Ordu C; Koksal U; Nur Pilanci K; Erdogan Z; Izci F; Elbuken F; Agacayak F; Aktepe F; Ozmen V
    J BUON; 2018; 23(6):1591-1600. PubMed ID: 30610782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study.
    Gao X; Fisher SG; Emami B
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1038-45. PubMed ID: 12829139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin's disease.
    Chadha M; Yoon H; Feldman S; Shah N; Moore E; Harrison LB
    Am J Clin Oncol; 2009 Apr; 32(2):132-6. PubMed ID: 19307955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma.
    Veit-Rubin N; Rapiti E; Usel M; Benhamou S; Vinh-Hung V; Vlastos G; Bouchardy C
    Oncologist; 2012; 17(6):783-91. PubMed ID: 22588325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.